FIELD: pharmaceutical chemistry.
SUBSTANCE: group of inventions includes a compound of formula (I) or a pharmaceutically acceptable salt thereof, as well as a pharmaceutical composition based on it. In formula (I) , A is a pyridine ring; Z is CH; R1 is selected from the group consisting of heterocycloalkyl, heterocycloalkyloxy, heterocycloalkyl-C1-6-alkoxy, 6–10-membered heterospirocycloalkyl containing 1–2 heteroatoms selected from oxygen and nitrogen, C3–6-cycloalkyl-C1–6-alkoxy, where heterocycloalkyl is a 4–6-membered heterocycloalkyl containing 1–2 heteroatoms selected from oxygen and nitrogen, and the nitrogen atom in heterocycloalkyl is optionally substituted with C 1–6 -alkyl; R2 is selected from the group consisting of halo and C1–6 haloalkyl; R3 is C1–6 alkyl.
EFFECT: using a compound of formula (I) as an inhibitor of PDGFR kinase activity, in particular PDGFR kinasesα and/or PDGFRβ.
12 cl, 5 dwg, 2 tbl, 45 ex
Title | Year | Author | Number |
---|---|---|---|
NEW PAN-RAF KINASE INHIBITOR AND APPLICATIONS THEREOF | 2019 |
|
RU2792626C1 |
PAN-KIT KINASE INHIBITOR HAVING QUINOLINE STRUCTURE AND ITS USE | 2018 |
|
RU2789405C2 |
PYRAZOLE COMPOUNDS, THEIR PHARMACEUTICAL COMPOSITIONS AND THEIR APPLICATION | 2019 |
|
RU2770835C1 |
HETEROCYCLIC COMPOUND, INTERMEDIATE COMPOUND, A METHOD OF ITS PRODUCTION AND ITS USE | 2019 |
|
RU2800153C2 |
PYRROLIDINE DERIVATIVES AS PPAR AGONISTS | 2017 |
|
RU2711991C1 |
PICOLINAMIDE AND PYRIMIDINE-4-CARBOXAMIDE COMPOUNDS, METHOD OF OBTAINING THEREOF AND THEREOF-CONTAINING PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2566827C2 |
PHENYL [A]INDOLE [2,3-G] QUINOLYSINS, THEIR PREPARATION METHOD, COMPOSITIONS CONTAINING THEM AND APPLICATION OPTIONS | 2017 |
|
RU2756197C2 |
COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS | 2006 |
|
RU2368602C2 |
AMIDE DERIVATIVES AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PREPARATION METHOD THEREFOR AND MEDICINAL APPLICATION THEREOF | 2015 |
|
RU2681537C2 |
NOVEL COMPOUNDS AND FASN INHIBITION COMPOSITIONS | 2014 |
|
RU2737434C2 |
Authors
Dates
2023-10-12—Published
2020-08-14—Filed